2006
DOI: 10.1136/jcp.2005.029876
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer

Abstract: Objective: To clarify the prognostic role of E-cadherin and b-and c-catenins, and their relation to CD44 in epithelial ovarian carcinoma. Methods: The expression of E-cadherin and b-and c-catenins was analysed immunohistochemically in 305 primary epithelial ovarian cancers and 44 metastases, and related to CD44 expression, clinicopathological factors, and the patients' survival. Results: Reduced cell surface expression of E-cadherin, b-catenin, and c-catenin was particularly frequent in serous and endometrioid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
46
1
2

Year Published

2007
2007
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 60 publications
(55 citation statements)
references
References 46 publications
(38 reference statements)
6
46
1
2
Order By: Relevance
“…The cell adhesion molecule E-cadherin has already been described to be involved in tumour dedifferentiation and poor recurrence-free survival in ovarian cancer (Imai et al, 2004;Voutilainen et al, 2006). We showed that reduced E-cadherin immunoreactivity in primary ovarian tumours was significantly (P ¼ 0.008) associated with shorter overall survival.…”
Section: Discussionmentioning
confidence: 52%
See 1 more Smart Citation
“…The cell adhesion molecule E-cadherin has already been described to be involved in tumour dedifferentiation and poor recurrence-free survival in ovarian cancer (Imai et al, 2004;Voutilainen et al, 2006). We showed that reduced E-cadherin immunoreactivity in primary ovarian tumours was significantly (P ¼ 0.008) associated with shorter overall survival.…”
Section: Discussionmentioning
confidence: 52%
“…Occurrence of altered E-cadherin expression has been correlated with dedifferentiation, increased risk of local invasion and metastatic disease, and recurrence and poor prognosis in a variety of carcinomas, for example, breast, uterine cervix, or gastric carcinomas (Moll et al, 1993;Fujimoto et al, 1997;Jawhari et al, 1997;Jeffers et al, 1997;Huiping et al, 2001). Previous studies have shown that reduced expression of E-cadherin in ovarian cancer is associated with the invasive phenotype, advancing tumour stage, lower 5-year survival rate, and poor recurrence-free survival (Faleiro-Rodrigues et al, 2004;Imai et al, 2004;Marques et al, 2004;Voutilainen et al, 2006) but not much is known about the underlying mechanisms of E-cadherin downregulation.…”
mentioning
confidence: 99%
“…In more advanced, poorly differentiated carcinomas, both absent and persistent E-cadherin expression have been reported [16,18,51,59]. While complete loss of E-cadherin expression is uncommon, reduced E-cadherin staining is often detected in late stage carcinomas and in ascites-derived tumor cells [59,62,63]. Correspondingly, ascites cells may be more invasive than paired solid tumor cells from the same patient [60].…”
Section: B Cadherin Expression In Eocmentioning
confidence: 99%
“…Particular cell-to-cell adhesion molecules, especially E-cadherin and associated catenins, are thought to be involved in progression of ovarian cancer. [15][16][17][18][19] Indeed, downregulation or abnormal expression of E-cadherincatenin proteins has been reported to be associated with poor histologic differentiation of tumors, increased risk of peritoneal metastasis, and poor patient outcome in ovarian cancer as well as in various solid cancers at other primary sites. [19][20][21][22][23][24] Although, for disease progression, ovarian cancer cells should require cell motility besides loss of cellto-cell adhesion, the molecular backgrounds underlying this process is still unclear.…”
mentioning
confidence: 99%